Profil
Melissa Abel is currently VP-Commercial Strategy & Communications at 89bio, Inc. Formerly, Ms. Abel worked in Sales & Marketing at Smithkline Beecham from 1995 to 1999.
From 2016 to 2020, Ms. Abel was Vice President-Commercial Strategy at both Five Prime Therapeutics, Inc. and Concentric Analgesics, Inc. Ms. Abel earned an MBA from Emory University and completed undergraduate studies at The University of Chicago.
Postes actifs de Melissa Abel
| Sociétés | Poste | Début |
|---|---|---|
| 89BIO, INC. | Public Communications Contact | - |
Anciens postes connus de Melissa Abel
| Sociétés | Poste | Fin |
|---|---|---|
| FIVE PRIME THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2020 |
Concentric Analgesics, Inc.
Concentric Analgesics, Inc. Packaged SoftwareTechnology Services Develops non-opioid therapeutics platform for pain management | Corporate Officer/Principal | 01/01/2020 |
Smithkline Beecham | Sales & Marketing | 02/01/1999 |
Formation de Melissa Abel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Five Prime Therapeutics, Inc.
Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
Emory University
Emory University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Smithkline Beecham | |
Concentric Analgesics, Inc.
Concentric Analgesics, Inc. Packaged SoftwareTechnology Services Develops non-opioid therapeutics platform for pain management | Technology Services |
89bio, Inc.
89bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
















